IN8bio says JCO publication shows INB-200 trial doubles progression-free survival in repeat-dose glioblastoma patientsPUBT·Jul 9 at 07:03 AMINAB+0.84%
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga_article·Jun 11 at 04:05 PMRDHL-5.22%INAB+0.84%
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | INAB Stock NewsStockTitan·Apr 3 at 07:00 AMBIB-0.85%SBIO-0.88%
